Validation of the Multiple Sclerosis International Quality of Life questionnaire
- PMID: 17942521
- DOI: 10.1177/1352458507080733
Validation of the Multiple Sclerosis International Quality of Life questionnaire
Abstract
This study aims to validate the Multiple Sclerosis (MS) International Quality of Life (MusiQoL) questionnaire, a multi-dimensional, self-administered questionnaire, available in 14 languages, as a disease-specific quality of life scale that can be applied internationally. A total of 1992 patients with different types and severities of MS from 15 countries were recruited. At baseline and day 21 +/- 7, each patient completed the MusiQoL, a symptom checklist and the short-form (SF)-36 QoL questionnaire. Neurologists also collected socio-demographic, MS history and outcome data. The database was randomly divided into two subgroups and analysed according to different patient characteristics. For each model, psychometric properties were tested and the number of items was reduced by various statistical methods. Construct validity, internal consistency, reproducibility and external consistency were also tested. Nine dimensions, explaining 71% of the total variance, were isolated. Internal consistency and reproducibility were satisfactory for all the dimensions. External validity testing revealed that dimension scores correlated significantly with all SF-36 scores, but showed discriminant validity by gender, socio-economic and health status. Significant correlations were found between activity in daily life scores and clinical indices. These results demonstrate the validity and reliability of the MusiQoL as an international scale to evaluate QoL in patients with MS.
Similar articles
-
Validation of the multiple sclerosis international quality of life (MusiQoL) questionnaire in Norwegian patients.Acta Neurol Scand. 2012 Mar;125(3):171-9. doi: 10.1111/j.1600-0404.2011.01518.x. Epub 2011 Apr 7. Acta Neurol Scand. 2012. PMID: 21470195
-
[French validation of the Multiple Sclerosis International Quality of Life Questionnaire].Rev Neurol (Paris). 2011 Jun-Jul;167(6-7):511-21. doi: 10.1016/j.neurol.2010.10.008. Epub 2011 Mar 21. Rev Neurol (Paris). 2011. PMID: 21420136 French.
-
[Quality of life and multiple sclerosis: validation of the french version of the self-questionnaire (SEP-59)].Rev Neurol (Paris). 2000 Mar;156(3):247-63. Rev Neurol (Paris). 2000. PMID: 10740096 French.
-
Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts.Urology. 2006 Aug;68(2 Suppl):9-16. doi: 10.1016/j.urology.2006.05.042. Urology. 2006. PMID: 16908336 Review.
-
An overview of obesity-specific quality of life questionnaires.Obes Rev. 2006 Nov;7(4):347-60. doi: 10.1111/j.1467-789X.2006.00244.x. Obes Rev. 2006. PMID: 17038129 Review.
Cited by
-
Upper Limb Dexterity in Patients with Multiple Sclerosis: An Important and Underrated Morbidity.Int J MS Care. 2021 Mar-Apr;23(2):79-84. doi: 10.7224/1537-2073.2019-083. Epub 2020 May 15. Int J MS Care. 2021. PMID: 33880084 Free PMC article.
-
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study.Health Qual Life Outcomes. 2013 Jul 29;11:127. doi: 10.1186/1477-7525-11-127. Health Qual Life Outcomes. 2013. PMID: 23895207 Free PMC article.
-
Validation of Persian Multiple Sclerosis quality of life-29 (P-MSQOL-29) questionnaire.Acta Neurol Belg. 2023 Dec;123(6):2201-2211. doi: 10.1007/s13760-023-02222-0. Epub 2023 Mar 18. Acta Neurol Belg. 2023. PMID: 36933177 Free PMC article.
-
Development and validation of the disease - specific problems questionnaire for patients with multiple sclerosis.BMC Neurol. 2021 Oct 27;21(1):415. doi: 10.1186/s12883-021-02442-y. BMC Neurol. 2021. PMID: 34706649 Free PMC article.
-
Deciphering Multiple Sclerosis Progression.Front Neurol. 2021 Apr 7;12:608491. doi: 10.3389/fneur.2021.608491. eCollection 2021. Front Neurol. 2021. PMID: 33897583 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical